ORIGINAL ARTICLESHYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS
References (21)
- et al.
Lancet
(1963) Lancet
(1961)Lancet
(1961)- et al.
Lancet
(1963) Lancet
(1962)Lancet
(1963)Lancet
(1962)Lancet
(1962)Lancet
(1963)Amer. J. Psychiat.
(1960)
There are more references available in the full text version of this article.
Cited by (217)
New insights into the toxicological effects of dietary biogenic amines
2024, Food ChemistryMonoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies
2022, European Journal of Medicinal ChemistryCitation Excerpt :In the treatment of brain disorders, monoamine oxidases are useful targets. Inhibition of this enzyme led to increase in the level of neurotransmitters like noradrenaline, serotonin and dopamine [69,70]. Clorgyline and pargyline are the irreversible inhibitors of MAO-A, employed in the therapy of anxiety and depression.
Biogenic amines and the winemaking process
2021, Managing Wine Quality: Volume 2: Oenology and Wine QualitySmear-Ripened Cheeses
2017, Cheese: Chemistry, Physics and Microbiology: Fourth EditionThe Relevance of Biogenic Amines in Dairy Products
2017, Dairy in Human Health and Disease across the Lifespan
Copyright © 1963 Published by Elsevier Ltd.